β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection

Area of Science:

• Microbiology
• Toxicology
• Pharmacology

Background:

• Pneumolysin is a key virulence factor of Streptococcus pneumoniae, belonging to the cholesterol-dependent cytolysin family.
• It causes cell lysis by forming pores in host cell membranes after binding to cholesterol.
• Antibiotic-killed bacteria still release active pneumolysin, necessitating alternative therapeutic strategies targeting the toxin itself.

Purpose of the Study:

• To investigate the potential of the phytosterol β-sitosterol as a therapeutic agent against pneumolysin-mediated cell damage.
• To determine the mechanism by which β-sitosterol interacts with pneumolysin.
• To evaluate the efficacy of β-sitosterol in protecting against S. pneumoniae infection in vivo.

Main Methods:

• In vitro assays to assess cell lysis inhibition by β-sitosterol.
• Analysis of β-sitosterol's interaction with pneumolysin, including binding site identification (Thr459, Leu460) and oligomerization.
• In vivo studies using a mouse model of S. pneumoniae infection.

Main Results:

• β-sitosterol effectively protected cells from lysis induced by pneumolysin.
• The compound binds to pneumolysin at specific sites (Thr459, Leu460), similar to cholesterol, and induces toxin oligomerization.
• β-sitosterol demonstrated protective effects against other cholesterol-dependent toxins and significantly improved survival rates in mice infected with S. pneumoniae.

Conclusions:

• β-sitosterol acts as a direct inhibitor of pneumolysin activity by interfering with its interaction with cell membranes.
• The findings support β-sitosterol's potential as a novel anti-virulence agent against Streptococcus pneumoniae and other pathogens utilizing cholesterol-dependent toxins.
• This phytosterol represents a promising candidate for developing new therapeutic strategies beyond conventional antibiotics.